• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄芪六一汤六种有效成分的肝脏药物主导代谢酶研究

Study on the liver Drug's dominant metabolic enzymes for six effective components of the Huang qi Liuyi decoction.

作者信息

Wang Qun, Tang Tiantian, Wu Zengguang, Yang Hong, Gao Yuan, Zhang Shiyu, Song Xinli, Chen Xiaolan

机构信息

Guizhou University of Traditional Chinese Medicine, Huaxi University Town, Guiyang, China.

National Research Center of Miao Medicine and Engineering Technology, Huaxi University Town, Guiyang, China.

出版信息

Front Pharmacol. 2023 Apr 14;14:1175896. doi: 10.3389/fphar.2023.1175896. eCollection 2023.

DOI:10.3389/fphar.2023.1175896
PMID:37124208
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10146250/
Abstract

To investigate the dominant metabolic enzymes of six effective components (astragaloside IV, glycyrrhizic acid, calycosin-glucuronide, formononetin, ononin, calycosin-7-O-β-D- glucoside) of Huangqi Liuyi decoction extract (HQD). Mouse liver microsomes were prepared. The effects of specific inhibitors of CYP450 enzymes on the metabolism of six effective components of HQD were studied using liver microsomal incubation . The chemical inhibitors of CYP2C37 inhibit the metabolism of glycyrrhizic acid and astragaloside IV. Formononetin and astragaloside IV metabolism is inhibited by the chemical inhibitors of CYP2C11. The chemical inhibitors of CYP2E1 and CYP1A2 inhibit the metabolism of calycosin-glucuronide. Chemical CYP3A11 inhibitors prevent formononetin and glycyrrhizic acid from being metabolized. However, no inhibitor significantly affected the metabolism of ononin and calycosin-7-O-β-D-glucoside. CYP2C37 may be involved in the metabolism of astragaloside IV and glycyrrhizic acid, the metabolism of astragaloside IV and formononetin may be related to CYP2C11, the metabolism of calycosin-glucuronide may be related to CYP1A2 and CYP2E1, and CYP3A11 may be involved in the metabolism of glycyrrhizic acid and formononetin. This research provides an experimental basis for exploring the pharmacokinetic differences caused by metabolic enzymes.

摘要

研究黄芪六一汤提取物(HQD)中六种有效成分(黄芪甲苷、甘草酸、毛蕊异黄酮葡萄糖醛酸苷、芒柄花素、鹰嘴豆芽素A、毛蕊异黄酮-7-O-β-D-葡萄糖苷)的主要代谢酶。制备小鼠肝微粒体。采用肝微粒体孵育法研究细胞色素P450酶(CYP450)特异性抑制剂对HQD六种有效成分代谢的影响。CYP2C37的化学抑制剂抑制甘草酸和黄芪甲苷的代谢。CYP2C11的化学抑制剂抑制芒柄花素和黄芪甲苷的代谢。CYP2E1和CYP1A2的化学抑制剂抑制毛蕊异黄酮葡萄糖醛酸苷的代谢。CYP3A11化学抑制剂可阻止芒柄花素和甘草酸的代谢。然而,没有抑制剂对鹰嘴豆芽素A和毛蕊异黄酮-7-O-β-D-葡萄糖苷的代谢产生显著影响。CYP2C37可能参与黄芪甲苷和甘草酸的代谢,黄芪甲苷和芒柄花素的代谢可能与CYP2C11有关,毛蕊异黄酮葡萄糖醛酸苷的代谢可能与CYP1A2和CYP2E1有关,CYP3A11可能参与甘草酸和芒柄花素的代谢。本研究为探讨代谢酶引起的药代动力学差异提供了实验依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfd/10146250/908e20cf98bf/fphar-14-1175896-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfd/10146250/8680dd9a7e7f/fphar-14-1175896-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfd/10146250/c696f7260570/fphar-14-1175896-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfd/10146250/60c6cb74471d/fphar-14-1175896-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfd/10146250/908e20cf98bf/fphar-14-1175896-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfd/10146250/8680dd9a7e7f/fphar-14-1175896-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfd/10146250/c696f7260570/fphar-14-1175896-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfd/10146250/60c6cb74471d/fphar-14-1175896-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dfd/10146250/908e20cf98bf/fphar-14-1175896-g004.jpg

相似文献

1
Study on the liver Drug's dominant metabolic enzymes for six effective components of the Huang qi Liuyi decoction.黄芪六一汤六种有效成分的肝脏药物主导代谢酶研究
Front Pharmacol. 2023 Apr 14;14:1175896. doi: 10.3389/fphar.2023.1175896. eCollection 2023.
2
Pharmacokinetic Difference of Six Active Constituents of Huangqi Liuyi Decoction between Control and Diabetic Nephropathy Mouse Models.黄芪六一汤六种活性成分在正常对照与糖尿病肾病小鼠模型中的药代动力学差异
Int J Anal Chem. 2022 May 25;2022:7602992. doi: 10.1155/2022/7602992. eCollection 2022.
3
Effects of Huangqi Liuyi Decoction in the Treatment of Diabetic Nephropathy and Tissue Distribution Difference of its Six Active Constituents Between Normal and Diabetic Nephropathy Mouse Models.黄芪六一汤治疗糖尿病肾病的效果及其六种活性成分在正常与糖尿病肾病小鼠模型中的组织分布差异
Front Pharmacol. 2022 Jun 21;13:934720. doi: 10.3389/fphar.2022.934720. eCollection 2022.
4
Mechanisms Underlying the Differences in the Pharmacokinetics of Six Active Constituents of Huangqi Liuyi Decoction between Normal and Diabetic Nephropathy Mouse Models.黄芪六一汤六种活性成分在正常和糖尿病肾病小鼠模型中药代动力学差异的潜在机制
Evid Based Complement Alternat Med. 2022 Oct 15;2022:2481654. doi: 10.1155/2022/2481654. eCollection 2022.
5
Simultaneous determination of calycosin-7-O-β-D-glucoside, ononin, calycosin, formononetin, astragaloside IV, and astragaloside II in rat plasma after oral administration of Radix Astragali extraction for their pharmacokinetic studies by ultra-pressure liquid chromatography with tandem mass spectrometry.采用超高效液相色谱-串联质谱法同时测定大鼠口服黄芪提取物后血浆中毛蕊异黄酮葡萄糖苷、芒柄花苷、毛蕊异黄酮、芒柄花素、黄芪甲苷和黄芪乙苷,用于其药代动力学研究。
Cell Biochem Biophys. 2014 Sep;70(1):677-86. doi: 10.1007/s12013-014-9972-x.
6
Simultaneous quantification of multiple components in rat plasma by UPLC-MS/MS and pharmacokinetic study after oral administration of Huangqi decoction.超高效液相色谱-串联质谱法同时定量大鼠血浆中多种成分及黄芪汤口服给药后的药代动力学研究
Biomed Chromatogr. 2018 May;32(5):e4178. doi: 10.1002/bmc.4178. Epub 2018 Jan 18.
7
Pharmacokinetics-based comprehensive strategy to identify multiple effective components in Huangqi decoction against liver fibrosis.基于药代动力学的综合策略鉴定黄芪汤抗肝纤维化的多种有效成分。
Phytomedicine. 2021 Apr;84:153513. doi: 10.1016/j.phymed.2021.153513. Epub 2021 Feb 18.
8
Fabrication of a bio-based polymer adsorbent and its application for extraction and determination of glycosides from Huangqi Liuyi decoction.制备一种基于生物的聚合物吸附剂及其在黄芪六益汤中苷类提取和测定中的应用。
J Pharm Biomed Anal. 2024 Mar 15;240:115947. doi: 10.1016/j.jpba.2023.115947. Epub 2023 Dec 29.
9
Absorption and metabolism of Astragali radix decoction: in silico, in vitro, and a case study in vivo.黄芪汤的吸收与代谢:计算机模拟、体外实验及体内病例研究
Drug Metab Dispos. 2006 Jun;34(6):913-24. doi: 10.1124/dmd.105.008300. Epub 2006 Feb 28.
10
Tissue distribution of six major bio-active components after oral administration of Zhenqi Fuzheng capsules to rats using ultra-pressure liquid chromatography-tandem mass spectrometry.采用超高效液相色谱-串联质谱法研究贞芪扶正胶囊灌胃大鼠后六种主要生物活性成分的组织分布。
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Apr 1;986-987:44-53. doi: 10.1016/j.jchromb.2015.01.033. Epub 2015 Feb 9.

引用本文的文献

1
Unveiling the Hub Genes Involved in Cadmium-Induced Hepatotoxicity.揭示镉诱导肝毒性中涉及的枢纽基因。
Biol Trace Elem Res. 2025 Apr;203(4):2186-2205. doi: 10.1007/s12011-024-04307-0. Epub 2024 Jul 16.

本文引用的文献

1
Mechanisms Underlying the Differences in the Pharmacokinetics of Six Active Constituents of Huangqi Liuyi Decoction between Normal and Diabetic Nephropathy Mouse Models.黄芪六一汤六种活性成分在正常和糖尿病肾病小鼠模型中药代动力学差异的潜在机制
Evid Based Complement Alternat Med. 2022 Oct 15;2022:2481654. doi: 10.1155/2022/2481654. eCollection 2022.
2
A Review of Traditional Chinese Medicine on Treatment of Diabetic Nephropathy and the Involved Mechanisms.中药治疗糖尿病肾病的研究进展及作用机制。
Am J Chin Med. 2022;50(7):1739-1779. doi: 10.1142/S0192415X22500744. Epub 2022 Oct 12.
3
Effects of Huangqi Liuyi Decoction in the Treatment of Diabetic Nephropathy and Tissue Distribution Difference of its Six Active Constituents Between Normal and Diabetic Nephropathy Mouse Models.
黄芪六一汤治疗糖尿病肾病的效果及其六种活性成分在正常与糖尿病肾病小鼠模型中的组织分布差异
Front Pharmacol. 2022 Jun 21;13:934720. doi: 10.3389/fphar.2022.934720. eCollection 2022.
4
Pharmacokinetic Difference of Six Active Constituents of Huangqi Liuyi Decoction between Control and Diabetic Nephropathy Mouse Models.黄芪六一汤六种活性成分在正常对照与糖尿病肾病小鼠模型中的药代动力学差异
Int J Anal Chem. 2022 May 25;2022:7602992. doi: 10.1155/2022/7602992. eCollection 2022.
5
Comparison of efficacy and safety of traditional Chinese patent medicines for diabetic nephropathy: A protocol for Bayesian network meta-analysis.比较治疗糖尿病肾病的中药专利药的疗效和安全性:贝叶斯网状Meta 分析方案。
Medicine (Baltimore). 2022 May 13;101(19):e29152. doi: 10.1097/MD.0000000000029152.
6
Metabolic characteristics and pharmacokinetic differences of Qiwei Tongbi oral liquid in rheumatoid arthritis rats.芪味通痹口服液在类风湿关节炎大鼠中的代谢特征和药代动力学差异。
Biomed Chromatogr. 2022 Jul;36(7):e5375. doi: 10.1002/bmc.5375. Epub 2022 Apr 13.
7
Effects of Shenkang Pills on Early-Stage Diabetic Nephropathy in db/db Mice Inhibiting AURKB/RacGAP1/RhoA Signaling Pathway.参康丸对db/db小鼠早期糖尿病肾病的影响:抑制AURKB/RacGAP1/RhoA信号通路
Front Pharmacol. 2022 Feb 11;13:781806. doi: 10.3389/fphar.2022.781806. eCollection 2022.
8
Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.基于网络药理学的黄芪治疗糖尿病肾病的 miRNA 表达研究。
Medicine (Baltimore). 2022 Feb 4;101(5):e28747. doi: 10.1097/MD.0000000000028747.
9
Comparative Studies on Multi-Component Pharmacokinetics of Thunb Extract After Oral Administration in Different Rat Models.不同大鼠模型口服独活提取物后多组分药代动力学的比较研究
Front Pharmacol. 2021 Jun 17;12:655332. doi: 10.3389/fphar.2021.655332. eCollection 2021.
10
Pharmacokinetics behaviors of -menthol after inhalation and intravenous injection in rats and its inhibition effects on CYP450 enzymes in rat liver microsomes.大鼠吸入和静脉注射后薄荷醇的药代动力学行为及其对大鼠肝微粒体中CYP450酶的抑制作用。
Xenobiotica. 2019 Oct;49(10):1183-1191. doi: 10.1080/00498254.2018.1537531. Epub 2019 Jun 11.